Gotham Therapeutics raises $54 mln
Gotham Therapeutics has raised $54 million in a Series A financing round led by Forbion and Versant Ventures. Also participating were SR One, Celgene and Alexandria Venture Investments. Forbion contributed $15 million to Gotham’s round. Gotham is a biotech that is developing a drug class targeting RNA-modifying proteins.
10 October 2018•3 mins read
